Abstract
Biomacromolecules play an important role in the treatment of many diseases, but their topical application has been limited by their poor cell membrane permeability. Cell-penetrating peptides (CPPs) have been investigated over the past few decades as a potential strategy to overcome this challenge. CPPs can effectively mediate the cellular uptake of poorly internalized biomacromolecules without unfavorable side effects and have therefore attracted considerable interest as a viable alternative to existing parenteral therapies involving biomacromolecules. In this review, we will highlight the application of CPPs to the non-invasive delivery of biomacromolecules, with a focus on percutaneous and nasal absorption of biomacromolecules administered using CPPs.
Keywords: Biomacromolecules, cell-penetrating peptide, intranasal delivery, non-invasive delivery, percutaneous delivery, topical administration.
Current Pharmaceutical Biotechnology
Title:Cell-Penetrating Peptide-Mediated Topical Delivery of Biomacromolecular Drugs
Volume: 15 Issue: 3
Author(s): Jiao Tan, Heesun Cheong, Yoon Shin Park, Hangun Kim, Meng Zhang, Cheol Moon and Yongzhuo Huang
Affiliation:
Keywords: Biomacromolecules, cell-penetrating peptide, intranasal delivery, non-invasive delivery, percutaneous delivery, topical administration.
Abstract: Biomacromolecules play an important role in the treatment of many diseases, but their topical application has been limited by their poor cell membrane permeability. Cell-penetrating peptides (CPPs) have been investigated over the past few decades as a potential strategy to overcome this challenge. CPPs can effectively mediate the cellular uptake of poorly internalized biomacromolecules without unfavorable side effects and have therefore attracted considerable interest as a viable alternative to existing parenteral therapies involving biomacromolecules. In this review, we will highlight the application of CPPs to the non-invasive delivery of biomacromolecules, with a focus on percutaneous and nasal absorption of biomacromolecules administered using CPPs.
Export Options
About this article
Cite this article as:
Tan Jiao, Cheong Heesun, Park Shin Yoon, Kim Hangun, Zhang Meng, Moon Cheol and Huang Yongzhuo, Cell-Penetrating Peptide-Mediated Topical Delivery of Biomacromolecular Drugs, Current Pharmaceutical Biotechnology 2014; 15 (3) . https://dx.doi.org/10.2174/1389201015666140617094320
DOI https://dx.doi.org/10.2174/1389201015666140617094320 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Tachykinergic System as Avenues for Drug Intervention
Recent Patents on CNS Drug Discovery (Discontinued) The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Current Neuropharmacology Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Current Drug Targets Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology PDGF-D Signaling: A Novel Target in Cancer Therapy
Current Drug Targets α<sub>IIb</sub>β<sub>3</sub>-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells
Current Drug Targets Placental Drug Transporters
Current Drug Metabolism Recent Developments in Tumor Angiogenesis
Current Pharmaceutical Biotechnology 99mTc-labeling of Peptidomimetic Antagonist to Selectively Target αvβ3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands
Current Radiopharmaceuticals Planar Cell Polarity Signaling in Collective Cell Movements During Morphogenesis and Disease
Current Genomics Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers
Current Medicinal Chemistry Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones
Current Pharmaceutical Design Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview
Current Drug Safety A Simplified Protocol Employing Elacridar in Rodents: A Screening Model in Drug Discovery to Assess P-gp Mediated Efflux at the Blood Brain Barrier
Drug Metabolism Letters An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent
Current Drug Delivery Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
Current Drug Safety